Hamilton Lane (NASDAQ:HLNE) Given New $190.00 Price Target at Morgan Stanley
by Scott Moore · The Cerbat GemHamilton Lane (NASDAQ:HLNE – Get Free Report) had its price objective boosted by stock analysts at Morgan Stanley from $182.00 to $190.00 in a report issued on Monday,Benzinga reports. The firm presently has an “equal weight” rating on the stock. Morgan Stanley’s price target would suggest a potential downside of 2.30% from the stock’s current price.
HLNE has been the topic of a number of other research reports. Keefe, Bruyette & Woods lifted their price target on Hamilton Lane from $181.00 to $215.00 and gave the stock a “market perform” rating in a research note on Thursday. JPMorgan Chase & Co. raised their price objective on Hamilton Lane from $134.00 to $175.00 and gave the stock a “neutral” rating in a research report on Thursday. The Goldman Sachs Group lifted their price target on Hamilton Lane from $139.00 to $147.00 and gave the company a “neutral” rating in a report on Thursday, October 3rd. UBS Group lifted their price target on Hamilton Lane from $150.00 to $185.00 and gave the company a “neutral” rating in a report on Tuesday, October 22nd. Finally, Wells Fargo & Company lifted their price target on Hamilton Lane from $156.00 to $170.00 and gave the stock an “equal weight” rating in a research report on Wednesday, October 9th. Seven analysts have rated the stock with a hold rating, According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $180.33.
Read Our Latest Stock Report on Hamilton Lane
Hamilton Lane Price Performance
NASDAQ:HLNE opened at $194.47 on Monday. The business’s 50-day moving average price is $169.23 and its 200 day moving average price is $142.99. The firm has a market cap of $10.54 billion, a P/E ratio of 42.18 and a beta of 1.18. Hamilton Lane has a 52-week low of $89.28 and a 52-week high of $196.60. The company has a quick ratio of 2.72, a current ratio of 3.37 and a debt-to-equity ratio of 0.24.
Hamilton Lane (NASDAQ:HLNE – Get Free Report) last released its earnings results on Wednesday, November 6th. The company reported $1.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.06 by $0.01. The firm had revenue of $150.00 million for the quarter, compared to analyst estimates of $151.55 million. Hamilton Lane had a return on equity of 35.59% and a net margin of 28.03%. Hamilton Lane’s revenue was up 18.2% compared to the same quarter last year. During the same period in the previous year, the company earned $0.89 earnings per share. As a group, sell-side analysts predict that Hamilton Lane will post 4.89 earnings per share for the current fiscal year.
Institutional Trading of Hamilton Lane
Several institutional investors have recently bought and sold shares of HLNE. Vanguard Group Inc. boosted its stake in Hamilton Lane by 8.3% in the first quarter. Vanguard Group Inc. now owns 3,678,617 shares of the company’s stock worth $414,801,000 after purchasing an additional 283,190 shares in the last quarter. American Century Companies Inc. boosted its stake in Hamilton Lane by 30.3% in the second quarter. American Century Companies Inc. now owns 580,768 shares of the company’s stock worth $71,772,000 after purchasing an additional 135,040 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund acquired a new position in Hamilton Lane in the first quarter worth $11,445,000. Principal Financial Group Inc. lifted its stake in shares of Hamilton Lane by 20.2% during the third quarter. Principal Financial Group Inc. now owns 583,721 shares of the company’s stock valued at $98,297,000 after acquiring an additional 97,924 shares during the period. Finally, Capital World Investors acquired a new position in shares of Hamilton Lane during the first quarter valued at $9,724,000. Institutional investors and hedge funds own 97.40% of the company’s stock.
About Hamilton Lane
Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.
Featured Articles
- Five stocks we like better than Hamilton Lane
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- 3 Under-the-Radar Healthcare Companies
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Globalstar: The Next Big Satellite Winner After Deal With Apple?
- 3 Fintech Stocks With Good 2021 Prospects
- Archer Aviation: Taking Off in Tokyo and Beyond?